SARS-CoV-2 Spike Trimer Protein, His Tag (KP.3) (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
SPN-S522e-100ug
$472.00
SPN-S522e-1mg (500ug X 2)
$2940.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    Spike, S protein, Spike glycoprotein, S glycoprotein

  • Source

    SARS-CoV-2 Spike Trimer Protein, His Tag (KP.3) (SPN-S522e) is expressed from human 293 cells (HEK293). It contains AA Val 16 -Pro 1213 (Accession # QHD43416.1 (T19I, R21T, LPP24-26Del, A27S, S50L, H69del, V70del, V127F, G142D, Y144del, F157S, R158G, N211del, L212I, V213G, L216F, H245N, A264D, I332V, G339H, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, V483del, E484K, F486P, Q493E, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, N764K, D796Y, S939F, Q954H, N969K, V1104L, P1143L, R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)). The recombinant protein is expressed from human 293 cells (HEK293) with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) and alanine substitutions (R683A and R685A) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein and abolish the furin cleavage site, respectively.

    Predicted N-terminus: Val 16

    Request for sequence

  • Molecular Characterization

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 137.7 kDa. The protein migrates as 150-180 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a trimer.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 0.1 M Sodium citrate, pH5.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Spike protein SDS-PAGE

    SARS-CoV-2 Spike Trimer Protein, His Tag (KP.3) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Spike protein SEC-MALS

    The purity of SARS-CoV-2 Spike Trimer Protein, His Tag (KP.3) (Cat. No. SPN-S522e) is more than 90% and the molecular weight of this protein is around 510-560 kDa verified by SEC-MALS.

    Report

Customer Reviews
Writing Reviews

Background

The spike protein of SARS-CoV-2 variant KP.3, a sublineage of Omicron JN.1, facilitates viral entry by binding the human ACE2 receptor through its receptor-binding domain. KP.3 carries characteristic mutations, including changes in the N-terminal and receptor-binding domains, that may enhance transmissibility and immune evasion. These alterations are under close surveillance for their potential impact on vaccine effectiveness, therapeutic antibody binding, and the ongoing evolution of SARS-CoV-2 in the global population.

Recent Advances

 
Drug Development Progress
  • English Name:

    Coronavirus spike glycoprotein

  • Category:

  • Approved Drugs:

    15 Details

  • Drugs in Clinical Trials:

    88 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호